A single treatment cycle consisted of 6 weeks of DF-521 administration period followed by 2 weeks observation period. DF-521 is administered every other day for 6 weeks(18 times in total) in the admin

2 trials

Sponsors

Yoshino Hiide

Conditions

Amyotrophic Lateral Sclerosis ALS

Unknown Phase

Exploratory clinical study of DF-521 in ALS (2)

Active, not recruitingJPRN-jRCTs031180059

Yoshino HiideAmyotrophic Lateral Sclerosis ALS

Start: 2017-10-16Target: 10Updated: 2026-06-29

Exploratory clinical study of DF-521 in ALS (3)

Active, not recruitingJPRN-jRCTs031180058

Yoshino HiideAmyotrophic Lateral Sclerosis ALS

Start: 2017-09-28Target: 10Updated: 2026-06-29